Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5Motor Activity 3Sleep Wake Disorders 2Overweight 2Ovarian Neoplasms 2Obesity 2Colorectal Neoplasms 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Cancer, Papillary 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Kidney Neoplasms 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Fatigue 1Endometrial Neoplasms 1Depressive Disorder 1Depression 1Castration-Resistant Prostate Cancer (CRPC) 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Carcinoma In Situ 1Anxiety Disorders 1

Interventions

Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Castration-Resistant Prostate Cancer (CRPC) × Counseling × 90 days × Clear all
NCT07240857 2026-05-22

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Zhejiang University

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Castration-Resistant Prostate Cancer (CRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡